We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Surgery Reverses Obesity-Related Hypogonadism

By HospiMedica International staff writers
Posted on 05 Jun 2018
A new study shows that weight loss after obesity surgery can rapidly restore testosterone production and sex drive in morbidly obese men.

Researchers at the University of Padova (Italy) conducted a study involving 29 obese men (average age 40.5 years, average body mass index (BMI) 43.4 kg/m2) who underwent a bariatric sleeve gastrectomy procedure. More...
Blood tests were performed before and one month after surgery to measure total plasma testosterone, the sex hormones dihydrotestosterone (DHT), estradiol, luteinising hormone (LH), follicle-stimulating hormone (FSH), sex hormone binding globulin (SHBG), prostatic-specific antigen (PSA), and leptin. A group of 19 healthy age-matched, non-obese, male subjects served as a control.

Among the obese subjects, 51.6% suffered from hypogonadism, and of those who had subnormal total testosterone, those with metabolic syndrome (45.2%) showed lower plasma testosterone than men without metabolic syndrome. BMI and waist circumference were found to be negatively correlated with total testosterone and plasma LH levels. The obese males had lower plasma testosterone (10.8 nmol/L) than healthy subjects (15.7 nmol/L), higher estradiol levels, and lower LH and FSH levels. No differences were observed between the two groups in their DHT and PSA levels.

The results revealed that one month after the sleeve gastrectomy procedure, obese subjects showed a significant weight reduction (averaging 17.2 kg) and the proportion with hypogonadism had fallen to just 11.6%. At the same time, average testosterone levels increased by 85%, to a level greater than that observed in the healthy control group (18.9 nmol/L), and estradiol levels fell by 35%. Surprisingly, PSA levels rose by 70%. The study was presented at the European Congress on Obesity (ECO), held during May 2018 in Vienna (Austria).

“Obesity in men is associated with hypogonadism, a condition in which production of testosterone is reduced, while estrogen levels are elevated,” said senior author Professor Marco Rossato, MD, and colleagues. “These effects seem to be the result of excess body fat interfering with sex steroid metabolism which leads to increased aromatization of androgens (such as testosterone) into estrogens within the adipose tissue itself. It follows that weight loss should improve this hormonal imbalance, and contribute to a reversal of hypogonadism.”

Hypogonadism in men refers to a diminished functional activity of the gonads, resulting in diminished testosterone biosynthesis. Other hormones produced by the gonads that hypogonadism can decrease include progesterone, DHEA, anti-Müllerian hormone, activin, and inhibin. In men, it can cause reduced body hair and beard, enlarged breasts, loss of muscle, and sexual difficulties.

Related Links:
University of Padova


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Brain-Computer Interface Enables Responses in Some Unresponsive ICU Patients

Cognitive motor dissociation occurs when patients retain signs of consciousness but cannot move or speak to communicate. In the ICU, this hidden consciousness can be difficult to distinguish from coma... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.